Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
US-2024117064-A1 · Apr 11, 2024 · US
Controlled activation ingestible identifier
US8945005B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8945005-B2 |
| Application number | US-44717207-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 25, 2007 |
| Priority date | Oct 25, 2006 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
First claim
Opening claim text (preview).
What is claimed is: 1. A pharmaceutical composition comprising: a pharmaceutical active agent; a controlled activation identifier that transmits a signal upon contact with a target site of a body, wherein the signal is a conductive signal and wherein the controlled activation identifier comprises first and second electrodes that are configured to create a voltaic cell when in contact with a conducting fluid at the target site, wherein the voltaic cell supplies power to the contr…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Electricity · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8945005B2 cover?
- Controlled activation identifiers for use in ingestible compositions, such as pharma-informatics enabled compositions, are provided. The identifiers include a controlled activation element that provides for activation of the identifier in response to the presence of a predetermined stimulus at a target site of interest. The invention finds use in a variety of different applications, including b…
- Who is the assignee on this patent?
- Hafezi Hooman, Robertson Timothy, Colliou Olivier, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K49/00. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).